HCG and Testosterone

HCG is one of the most misunderstood compounds in the hormonal health space. Most people associate it with pregnancy testing or, in fitness circles, with post-cycle therapy after steroid use. Both associations have merit, but they miss what is arguably the most clinically important use of HCG: supporting the body's own testosterone production system, both during and after testosterone replacement therapy.

Understanding how HCG fits into the hormonal health picture requires understanding a bit of the underlying biology first.

The Testosterone Production System: A Brief Overview

Testosterone production in men is regulated by a cascade called the Hypothalamic-Pituitary-Gonadal (HPG) axis.

The hypothalamus releases GnRH (Gonadotropin-Releasing Hormone) in pulses. GnRH signals the pituitary gland to release two hormones: LH (Luteinising Hormone) and FSH (Follicle-Stimulating Hormone). LH travels to the testes and binds to receptors on Leydig cells, the specialised cells responsible for testosterone production. FSH supports spermatogenesis (sperm production) in the Sertoli cells.

The Leydig cells, stimulated by LH, produce and secrete testosterone into the bloodstream. As testosterone levels rise, the hypothalamus and pituitary detect this and reduce GnRH and LH output, creating a negative feedback loop that keeps testosterone within a normal range.

This system is elegant but fragile. Anything that disrupts LH signalling to the testes will reduce testosterone production and, over time, cause the testes to reduce their capacity to respond to LH.

What Is HCG?

Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone produced by the placenta during pregnancy. It maintains the corpus luteum, which produces progesterone to support the early pregnancy. HCG is the hormone detected by pregnancy tests.

In men, HCG has a critical and somewhat surprising role: it closely resembles LH and binds to the same receptor on Leydig cells. When HCG binds to the LH receptor, it stimulates testosterone production in exactly the same way that endogenous LH does. From the Leydig cell's perspective, HCG and LH are functionally interchangeable.

This is the property that makes HCG so useful in male hormonal health: it can substitute for, or supplement, the LH signal that drives testicular testosterone production.

Why HCG Matters in Testosterone Replacement Therapy

Testosterone Replacement Therapy (TRT) is prescribed for men with clinically low testosterone. It effectively raises testosterone levels, but it creates a significant downstream problem that many men and their prescribing physicians under-appreciate.

When exogenous testosterone is introduced, the brain detects the elevated testosterone and suppresses the HPG axis. GnRH output drops, LH falls, and the testes receive no signal to produce testosterone. Without LH stimulation, the testes atrophy over time, losing both testosterone-producing capacity and sperm production ability. Testicular atrophy is both visually apparent and functionally significant.

HCG solves this problem. When used alongside TRT, HCG maintains direct stimulation of the Leydig cells through the LH receptor, even in the absence of endogenous LH. This preserves testicular size and function during TRT, maintains some intrinsic testosterone production and preserves fertility to a meaningful degree.

The practical result is that men on TRT who also use HCG maintain the benefits of testosterone optimisation while avoiding many of the long-term consequences of complete HPG axis suppression. HCG is now increasingly considered a standard component of well-designed TRT protocols rather than an optional add-on.

HCG in Post-Cycle Therapy (PCT)

For men who have used anabolic steroids or supraphysiological doses of testosterone for performance purposes and who wish to restore natural testosterone production afterwards, HCG is typically the first phase of post-cycle therapy.

After a steroid cycle, the HPG axis is suppressed. The testes have been without LH stimulation for an extended period and their Leydig cells may have reduced responsiveness. HCG is used in the immediate post-cycle period to directly stimulate Leydig cells and kickstart testosterone production while the HPG axis gradually recovers. This is followed by SERM therapy (such as Nolvadex or Clomid) to restore the natural LH signal.

The sequencing matters. Using HCG for too long during PCT can paradoxically desensitise LH receptors. Most PCT protocols use HCG for two to four weeks post-cycle before transitioning to SERM-based restoration.

HCG and Fertility

One of HCG's most important applications in male health is fertility preservation or restoration. Because FSH (also suppressed by exogenous testosterone) is required for spermatogenesis, HCG alone does not fully restore fertility. But it is an important first component.

For men on TRT who wish to conceive, a protocol combining HCG with FSH (either recombinant FSH or HMG, a combination of LH and FSH activity) can restore spermatogenesis in a significant proportion of cases. This approach is increasingly offered by fertility-aware urologists and reproductive endocrinologists.

For men who are hypogonadal but wish to remain fertile, HCG-based therapy is sometimes used as an alternative to TRT precisely because it stimulates endogenous testosterone production without suppressing the HPG axis.

Dosing Considerations

HCG is administered subcutaneously. In TRT support protocols, common dosing is 500 to 1,000 IU two to three times per week, administered alongside testosterone. In PCT protocols, higher doses (1,000 to 2,500 IU) are used for a shorter duration.

HCG is measured in International Units (IU) rather than micrograms or milligrams, which differentiates it from most other peptides discussed in this series. Reconstitution and dosing calculations follow the same principles, but the unit of measurement is important to keep straight.

Side effects can include elevated oestrogen (since HCG stimulates testicular testosterone, which can aromatise to oestrogen), which may require aromatase inhibitor management in some men, and polycythaemia risk when combined with TRT. These considerations reinforce the importance of appropriate monitoring when using HCG as part of a hormonal health protocol.

Disclaimer: The information in this article is for educational purposes only. Hormonal health interventions have significant implications for the endocrine system and should be managed with professional medical oversight wherever possible. Always consult a qualified healthcare professional before beginning any hormonal protocol.